Related Experiment Videos
[Mesenchymal breast sarcomas: general review]
M Spielmann1, L Zelek, A Llombart
1Service de Médecine B, Institut Gustave-Roussy, Villejuif.
Archives D'Anatomie Et De Cytologie Pathologiques
|January 1, 1995
Summary
Breast sarcomas are rare malignant tumors. Surgery is the main treatment, with adjuvant irradiation potentially improving local control, while chemotherapy
Area of Science:
- Oncology
- Surgical Pathology
Context:
- Breast sarcomas are rare, comprising 1% of all malignant breast tumors.
- Histological subtypes include fibrosarcomas and malignant fibrohistiocytomas.
- Nodal involvement is infrequent; hematogenous metastasis is more common.
Purpose:
- To review the characteristics, prognosis, and treatment of breast sarcomas.
Summary:
- Prognostic factors include histological grade and mitotic activity, with 3-year disease-free survival between 40-60%.
- Surgical resection is the primary treatment modality.
- Adjuvant irradiation may enhance local control, particularly after conservative surgery; the role of chemotherapy is uncertain.
Impact:
- This review provides insights into the management of rare breast sarcomas.
- Highlights the importance of histological grade and mitotic activity for prognosis.
- Informs treatment decisions regarding surgery, adjuvant irradiation, and chemotherapy for breast sarcomas.